133 related articles for article (PubMed ID: 38359747)
1. Endurance exercise preconditioning alleviates ferroptosis induced by doxorubicin-induced cardiotoxicity through mitochondrial superoxide-dependent AMPKα2 activation.
Wang L; Qiao Y; Yu J; Wang Q; Wu X; Cao Q; Zhang Z; Feng Z; He H
Redox Biol; 2024 Apr; 70():103079. PubMed ID: 38359747
[TBL] [Abstract][Full Text] [Related]
2. Salidroside pretreatment alleviates ferroptosis induced by myocardial ischemia/reperfusion through mitochondrial superoxide-dependent AMPKα2 activation.
Yang B; Xu Y; Yu J; Wang Q; Fan Q; Zhao X; Qiao Y; Zhang Z; Zhou Q; Yin D; He M; He H
Phytomedicine; 2024 Jun; 128():155365. PubMed ID: 38552436
[TBL] [Abstract][Full Text] [Related]
3. Epigallocatechin-3-gallate pretreatment alleviates doxorubicin-induced ferroptosis and cardiotoxicity by upregulating AMPKα2 and activating adaptive autophagy.
He H; Wang L; Qiao Y; Yang B; Yin D; He M
Redox Biol; 2021 Nov; 48():102185. PubMed ID: 34775319
[TBL] [Abstract][Full Text] [Related]
4. WGX50 mitigates doxorubicin-induced cardiotoxicity through inhibition of mitochondrial ROS and ferroptosis.
Tai P; Chen X; Jia G; Chen G; Gong L; Cheng Y; Li Z; Wang H; Chen A; Zhang G; Zhu Y; Xiao M; Wang Z; Liu Y; Shan D; He D; Li M; Zhan T; Khan A; Li X; Zeng X; Li C; Ouyang D; Ai K; Chen X; Liu D; Liu Z; Wei D; Cao K
J Transl Med; 2023 Nov; 21(1):823. PubMed ID: 37978379
[TBL] [Abstract][Full Text] [Related]
5. Activation of AMPKα2 attenuated doxorubicin-induced cardiotoxicity via inhibiting lipid peroxidation associated ferroptosis.
Liao HH; Ding W; Zhang N; Zhou ZY; Ling Z; Li WJ; Chen S; Tang QZ
Free Radic Biol Med; 2023 Aug; 205():275-290. PubMed ID: 37331642
[TBL] [Abstract][Full Text] [Related]
6. Neutrophil extracellular traps mediate cardiomyocyte ferroptosis via the Hippo-Yap pathway to exacerbate doxorubicin-induced cardiotoxicity.
Zhao P; Li Y; Xu X; Yang H; Li X; Fu S; Guo Z; Zhang J; Li H; Tian J
Cell Mol Life Sci; 2024 Mar; 81(1):122. PubMed ID: 38456997
[TBL] [Abstract][Full Text] [Related]
7. Endurance Exercise Attenuates Doxorubicin-induced Cardiotoxicity.
Lee Y; Kwon I; Jang Y; Cosio-Lima L; Barrington P
Med Sci Sports Exerc; 2020 Jan; 52(1):25-36. PubMed ID: 31318716
[TBL] [Abstract][Full Text] [Related]
8. Protective Role of Dioscin against Doxorubicin-Induced Chronic Cardiotoxicity: Insights from Nrf2-GPX4 Axis-Mediated Cardiac Ferroptosis.
Liu J; Liu H; Deng L; Wang T; Li L; Chen Y; Qu L; Zou W
Biomolecules; 2024 Mar; 14(4):. PubMed ID: 38672439
[TBL] [Abstract][Full Text] [Related]
9. By restoring autophagic flux and improving mitochondrial function, corosolic acid protects against Dox-induced cardiotoxicity.
Che Y; Wang Z; Yuan Y; Zhou H; Wu H; Wang S; Tang Q
Cell Biol Toxicol; 2022 Jun; 38(3):451-467. PubMed ID: 34296331
[TBL] [Abstract][Full Text] [Related]
10. Activation of p62-NRF2 Axis Protects against Doxorubicin-Induced Ferroptosis in Cardiomyocytes: A Novel Role and Molecular Mechanism of Resveratrol.
Yu W; Chen C; Xu C; Xie D; Wang Q; Liu W; Zhao H; He F; Chen B; Xi Y; Yan Y; Yu L; Cheng J
Am J Chin Med; 2022; 50(8):2103-2123. PubMed ID: 36309811
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of METTL3 ameliorates doxorubicin-induced cardiotoxicity through suppression of TFRC-mediated ferroptosis.
Wu L; Du Y; Wang L; Zhang Y; Ren J
Redox Biol; 2024 Jun; 72():103157. PubMed ID: 38631119
[TBL] [Abstract][Full Text] [Related]
12. FUNDC1 alleviates doxorubicin-induced cardiotoxicity by restoring mitochondrial-endoplasmic reticulum contacts and blocked autophagic flux.
He W; Sun Z; Tong G; Zeng L; He W; Chen X; Zhen C; Chen P; Tan N; He P
Theranostics; 2024; 14(9):3719-3738. PubMed ID: 38948070
[No Abstract] [Full Text] [Related]
13. Ginsenoside Rb1 attenuates doxorubicin induced cardiotoxicity by suppressing autophagy and ferroptosis.
Zhai Y; Bai J; Peng Y; Cao J; Fang G; Dong Y; Wang Z; Lu Y; Wang M; Liu M; Liu Y; Li X; Dong J; Zhao X
Biochem Biophys Res Commun; 2024 May; 710():149910. PubMed ID: 38593619
[TBL] [Abstract][Full Text] [Related]
14. Salidroside inhibits doxorubicin-induced cardiomyopathy by modulating a ferroptosis-dependent pathway.
Chen H; Zhu J; Le Y; Pan J; Liu Y; Liu Z; Wang C; Dou X; Lu D
Phytomedicine; 2022 May; 99():153964. PubMed ID: 35180677
[TBL] [Abstract][Full Text] [Related]
15. LCZ696 protects against doxorubicin-induced cardiotoxicity by inhibiting ferroptosis via AKT/SIRT3/SOD2 signaling pathway activation.
Liu X; Li D; Pi W; Wang B; Xu S; Yu L; Yao L; Sun Z; Jiang J; Mi Y
Int Immunopharmacol; 2022 Dec; 113(Pt A):109379. PubMed ID: 36330913
[TBL] [Abstract][Full Text] [Related]
16. Doxorubicin causes ferroptosis and cardiotoxicity by intercalating into mitochondrial DNA and disrupting Alas1-dependent heme synthesis.
Abe K; Ikeda M; Ide T; Tadokoro T; Miyamoto HD; Furusawa S; Tsutsui Y; Miyake R; Ishimaru K; Watanabe M; Matsushima S; Koumura T; Yamada KI; Imai H; Tsutsui H
Sci Signal; 2022 Nov; 15(758):eabn8017. PubMed ID: 36318618
[TBL] [Abstract][Full Text] [Related]
17. Qishen granule attenuates doxorubicin-induced cardiotoxicity by protecting mitochondrial function and reducing oxidative stress through regulation of Sirtuin3.
Zhang J; Li W; Xue S; Gao P; Wang H; Chen H; Hong Y; Sun Q; Lu L; Wang Y; Wang Q
J Ethnopharmacol; 2024 Jan; 319(Pt 1):117134. PubMed ID: 37714227
[TBL] [Abstract][Full Text] [Related]
18. Ethoxyquin is a Competent Radical-Trapping Antioxidant for Preventing Ferroptosis in Doxorubicin Cardiotoxicity.
Tadokoro T; Ikeda M; Abe K; Ide T; Miyamoto HD; Furusawa S; Ishimaru K; Watanabe M; Ishikita A; Matsushima S; Koumura T; Yamada KI; Imai H; Tsutsui H
J Cardiovasc Pharmacol; 2022 Nov; 80(5):690-699. PubMed ID: 35881422
[TBL] [Abstract][Full Text] [Related]
19. Resveratrol protects against doxorubicin-induced cardiotoxicity by attenuating ferroptosis through modulating the MAPK signaling pathway.
Chen L; Sun X; Wang Z; Chen M; He Y; Zhang H; Han D; Zheng L
Toxicol Appl Pharmacol; 2024 Jan; 482():116794. PubMed ID: 38142782
[TBL] [Abstract][Full Text] [Related]
20. Mitochondria-dependent ferroptosis plays a pivotal role in doxorubicin cardiotoxicity.
Tadokoro T; Ikeda M; Ide T; Deguchi H; Ikeda S; Okabe K; Ishikita A; Matsushima S; Koumura T; Yamada KI; Imai H; Tsutsui H
JCI Insight; 2020 May; 5(9):. PubMed ID: 32376803
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
